TVTY Tivity Health Inc.

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed a Complaint on Behalf of Tivity Health, Inc. Shareholders and Lead Plaintiff Deadline of January 19, 2018

The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of Tivity Health, Inc. ("Tivity Health") (NASDAQ: TVTY) between February 24, 2017 and November 3, 2017. You are hereby notified that Levi & Korsinsky filed Weiner v. Tivity Health, Inc., et al. (3:17-CV-01469) a securities class action lawsuit in the United States District Court for the Middle District of Tennessee, Nashville Division. To get more information go to:

http://www.zlk.com/pslra-sbm/tivity-health-inc?wire=2

or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) Tivity Health was aware that its customer United Healthcare, Inc. planned to expand its fitness benefit to seniors, (ii) the aforementioned expansion would represent direct competition to Tivity Health’s core program SilverSneaker, and (iii) as a result of the foregoing, the Company’s financial statements, as well as Defendants’ statements about Tivity Health’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.

If you suffered a loss in Tivity you have until January 19, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

EN
11/12/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Tivity Health Inc.

Moody's says Tivity Health's ratings unchanged following announcement ...

Moody's Investors Service ("Moody's") said Tivity Health, Inc.'s ("Tivity Health") B2 Corporate Family Rating, B2-PD Probability of Default Rating and B2 ratings of the senior secured bank credit facility, consisting a revolver and a term loan B, are unchanged following the company's announcement on...

TIVITY HEALTH reduced its risk exposure resulting in an upgrade to Sli...

TIVITY HEALTH (US), a company active in the Health Care Providers industry, reduced its market risk and raised its general evaluation. The independent financial analyst theScreener awarded an improved star rating to the company, which now shows 3 out of 4 possible stars; its market behaviour has improved and can be considered as defensive. theScreener believes that this new assessment merits an overall rating upgrade to Slightly Positive. As of the analysis date April 1, 2022, the closing price ...

Tivity Health, Inc.: Update to credit analysis

Our credit view of Tivity Health reflects its solid credit metrics including modest financial leverage, against business and customer concentration risks

Moody's announces completion of a periodic review of ratings of Tivity...

Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Tivity Health, Inc.. Global Credit Research- 11 Jan 2022. New York, January 11, 2022-- Moody's Investors Service has completed a periodic review of the ratings of Tivity Health, Inc. and other ratings that are associated with the same analytical unit.

Tivity Health Inc: 1 director

A director at Tivity Health Inc sold 36,810 shares at 27.090USD and the significance rating of the trade was 76/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch